Prevalence and clinical characteristics associated with left atrial thrombus detection: Apixaban.

CONCLUSION: Among patients with non-valvular AF and ≥ 4 wk of anticoagulation with apixaban, the prevalence of LAA thrombus detected by TEE was 3.1%. This suggests that continuous therapy with apixaban does not completely eliminate the risk of LAA thrombus and that TEE prior to cardioversion or catheter ablation may be of benefit in patients with multiple risk factors.
PMID: 30820278 [PubMed]

Source: World Journal of Cardiology - February 25, 2019 Category: Cardiology Authors: Whiteside HL, Nagabandi A, Brown K, Ayyala DN, Sharma GK Tags: World J Cardiol Source Type: research